drugset / Trial / NCT04118777

Postoperative Narcotic Use After Laparoscopic Gynecologic Surgery

NCT04118777 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This will be a prospective, randomized, double blinded placebo-controlled study at Erlanger hospital. Eligible patients who provide consent will be randomized into one of two arms receiving continuous intra-peritoneal local anesthetic with 0.2% Ropivacaine or saline.

Timeline

Start
2020-05-01
Primary completion
2020-06-30
Completion
2020-07-30

Outcome

Outcome not reported

Stopped: “Misregistered to wrong sponsor.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 0.2 % Other